Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients
NCT04096222 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2022-08-10
Summary
This study will compare the pattern of Th17 immune response in active and inactive pemphigus subjects. Skin and serum samples will be taken at the moment of enrollment.
Conditions
- Pemphigus Vulgaris
- Bullous Dermatoses
- Autoimmune Diseases
Sponsors & Collaborators
-
Hospital General Dr. Manuel Gea González
collaborator OTHER_GOV -
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
lead OTHER
Principal Investigators
-
Luis Guillermo Llorente Peters, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-29
- Primary Completion
- 2023-03-28
- Completion
- 2023-03-28
Countries
- Mexico
Study Locations
More Related Trials
-
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
NCT04465292 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
NCT06949241 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
NCT04206553 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment
NCT01688882 ·Status: TERMINATED ·Phase: PHASE2
-
Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid
NCT06479018 ·Status: RECRUITING ·Phase: NA
-
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
NCT00483119 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
NCT05303272 ·Status: UNKNOWN ·Phase: PHASE4
-
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
NCT02315417 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06411379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Rituximab in the Treatment of Patients With Bullous Pemphigoid
NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Use of KC706 for the Treatment of Pemphigus Vulgaris
NCT00606749 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
NCT00072592 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
NCT02613910 ·Status: TERMINATED ·Phase: PHASE3
-
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
NCT01211977 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of Bermekimab in Patients With Hidradenitis Suppurativa
NCT03512275 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
NCT04128176 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06411899 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy
NCT04641884 ·Status: UNKNOWN
-
Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
NCT01974518 ·Status: UNKNOWN ·Phase: PHASE3
-
JAK Inhibitors' Efficacy in Bullous Pemphigoid
NCT06561256 ·Status: COMPLETED
-
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
NCT04501666 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
NCT05322473 ·Status: COMPLETED ·Phase: PHASE2
-
Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
NCT00525616 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
NCT04762277 ·Status: COMPLETED ·Phase: PHASE2
-
Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid
NCT00802243 ·Status: UNKNOWN ·Phase: PHASE2